Charlie’s Holdings, Inc. reports developments in premium vapor products and electronic nicotine delivery systems. The company sells product lines including SBX, Pachamama and PACHA through distributors, specialty retailers and online resellers, with operating activity tied to Charlie’s Chalk Dust, LLC.
Recurring updates center on FDA Premarket Tobacco Product Applications, state vapor-product requirements, age-verification technology for device activation, product-line distribution, trade-show participation, financial results and capital actions such as private placements and debt forgiveness.
Charlie’s Holdings (OTCQB: CHUC) reported 2025 revenue of $20.9 million (up 169% YoY) and net income of $4.5 million, reversing a $4.2 million loss in 2024. The 2025 audit received an unqualified opinion and removed the "going concern" paragraph, and the company intends to uplist in 2026.
Key balance sheet items: cash $1.3M, total assets $11.6M, shareholders’ equity $3.4M. PMTA asset sales generated $7.5M with $4.2M contingent consideration possible.
Charlie's Holdings (OTCQB: CHUC) closed a private placement on Feb 13, 2026, selling 3,550,000 shares at $0.20 for $710,000 (cash $510,000; $200,000 via debt forgiveness).
Proceeds will fund PMTA age-gating amendments and working capital. Insiders own nearly 50% of shares and purchased an additional 1,350,000 shares in the offering.
Charlie's Holdings (OTCQB:CHUC) announced that California granted Unflavored Tobacco List (UTL) approval for its Virginia Tobacco 25K-puff SBX product on February 12, 2026, making SBX the first and only 25K-puff vape legal to sell in California.
The release notes AB 3218 (effective January 1, 2025) created the UTL; only products on the UTL are legal to sell and non-listed products may be seized or face civil penalties.
Charlie's Holdings (OTCQB:CHUC) announced that Board member Dr. Ed Carmines was selected as a panelist for the FDA Roundtable on PMTA submissions for ENDS held February 10, 2026 at FDA headquarters.
Dr. Carmines will discuss pharmacokinetic studies and adult-benefit data for Charlie's PACHA™ disposable e-cigarette, and the roundtable will be viewable online.
Charlie's Holdings (OTCQB:CHUC) will present at two investor conferences in January 2026 as the company pursues an uplist to a national exchange. Presentations by President Henry Sicignano are scheduled for Jan 21, 2026 at 10:00 a.m. EST at the Sequire Investor Summit in Puerto Rico and Jan 28, 2026 at 11:30 a.m. EST at the Deal Flow Discovery Conference in Atlantic City.
The company says it is profitable, growing, has a clean balance sheet with no outstanding warrants and very little debt, and is monetizing SBX, U.S.-filled Pachamama sales and PMTA-submitted PACHA synthetic nicotine products to meet uplist requirements. Individual investor meetings are available by email to suzanne@chuc.com.
Charlie's Holdings (OTCQB: CHUC) announced a strategic licensing agreement with IKE Tech on January 6, 2026 to integrate IKE's AI-powered, blockchain-based age-gating platform into Charlie's SBX product line.
The deal delivers IKE BLE chips and a white-labeled web app, includes a limited exclusivity period for Charlie's nicotine analogue products, and references an IKE FDA-submitted platform that reportedly achieved 100% effectiveness in clinical validation studies at preventing underage activation. Integration into FDA-regulated ENDS devices is planned upon receiving marketing authorization.
Charlie's Holdings (OTCQB:CHUC) signed a definitive license with IKE Tech to commercialize an AI-powered, blockchain-based age-gating system for vape products and will test market the system this spring with its SBX nicotine analogue line while also planning integration into PACHA ENDS.
Key claims include a multi-center Human Factors Validation Study reporting 100% age verification, 0% underage activation, and 100% automatic deactivation. The agreement grants three-year exclusivity for age-gated nicotine analogue products and is positioned to address FDA youth-access priorities.
Charlie's Holdings (OTCQB:CHUC) opened its first US manufacturing facility in Huntington Beach, California and this week began shipping its US-filled Pachamama 25K disposables to 300 retail stores in Texas. The US-filling operation is designed to meet new state domestic-manufacturing requirements effective Sept 1, 2025, allowing Charlie's to sell products to Texas and other states with similar laws.
Management said it will devote 100% of current US manufacturing capacity to Texas and expects strong demand that could materially affect 2026 sales if US capacity is expanded.
Charlie's Holdings (OTCQB: CHUC) reported Q3 2025 revenue of $7.1 million, a 336% increase versus Q3 2024, and returned to profitability with net income of $0.6 million versus a $1.0 million loss a year earlier. Gross profit was $1.8 million (24.9% margin). The company said SBX rollout began in seven states and now represents the majority of sales. Charlie's completed a $1.0 million PMTA asset sale in August, bringing PMTA-related proceeds to $7.5 million with $4.2 million contingent. Cash was $1.1 million and total assets $10.6 million. Management expects continued growth and a US filling line opening in Q4 2025.
Charlies Holdings (OTCQB:CHUC) announced on November 13, 2025 that it will discontinue sales of all hemp/CBD products and permanently wind down and close its Don Polly division.
The company said the move aims to remove hemp/CBD-related trading restrictions imposed by national exchanges and major U.S. brokers, and to facilitate a potential uplist to a national securities exchange and increase liquidity in Charlies common stock. Management stated Don Polly sales are minor relative to 2026 SBX projections and that the companys non-nicotine SBX disposables are now the primary business focus.